ID   POVD
AC   CVCL_Y194
DR   cancercelllines; CVCL_Y194
DR   ChEMBL-Cells; CHEMBL3833601
DR   Cosmic; 1434970
DR   PubChem_Cell_line; CVCL_Y194
DR   Wikidata; Q54947764
RX   PubMed=7506562;
RX   PubMed=9134423;
RX   PubMed=9274917;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Unspecified (PubMed=9274917).
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 10
//
RX   PubMed=7506562; DOI=10.1016/0959-8049(93)90465-R;
RA   Martignone S., Menard S., Bedini A., Paccagnella A., Fasolato S.,
RA   Veggian R., Colnaghi M.I.;
RT   "Study of the expression and function of the tumour-associated antigen
RT   CaMBr1 in small cell lung carcinomas.";
RL   Eur. J. Cancer 29A:2020-2025(1993).
//
RX   PubMed=9134423; DOI=10.1093/glycob/7.2.173;
RA   Adobati E., Panza L., Russo G., Colnaghi M.I., Canevari S.;
RT   "In vitro mimicry of CaMBr1 tumor-associated antigen by synthetic
RT   oligosaccharides.";
RL   Glycobiology 7:173-178(1997).
//
RX   PubMed=9274917; DOI=10.1093/jnci/89.16.1217;
RA   Arcamone F., Animati F., Berettoni M., Bigioni M., Capranico G.,
RA   Casazza A.M., Caserini C., Cipollone A., De Cesare M., Franciotti M.,
RA   Lombardi P., Madami A., Manzini S., Monteagudo E., Polizzi D.,
RA   Pratesi G., Righetti S.C., Salvatore C., Supino R., Zunino F.;
RT   "Doxorubicin disaccharide analogue: apoptosis-related improvement of
RT   efficacy in vivo.";
RL   J. Natl. Cancer Inst. 89:1217-1223(1997).
//